The all-out effort to make all opioid pain-relieving medications more difficult to get continues. Last week an FDA panel voted 19 to 10 to reclassify medications that contain hydrocodone – like Vicodin and Lortab – from Schedule III drugs to Schedule II drugs.
Currently, under the federal Controlled Substances Act, medications containing hydrocodone are classified as Schedule III drugs. This means doctors can call in or fax prescriptions to the pharmacy and can allow up to five refills in a six-month period.
If hydrocodone-containing products are reclassified to Schedule II, only written prescriptions with an original signature by the physician are acceptable and no refills are allowed. If you take a hydrocodone medication on a regular basis, that means in most cases you'll have to go to your doctor's office every month to get a new prescription.
The DEA (Drug Enforcement Administration) does allow, but does not encourage, doctors to issue multiple pre...
On Monday, the pharmaceutical company Zogenix, Inc. announced the FDA had accepted for review their New Drug Application (NDA) for Zohydro ER™ (hydrocodone bitartrate extended-release capsules).
Hydrocodone is one of the most frequently prescribed opioid drugs for the management of moderate to severe chronic pain. There are, however, two features that set Zohydro ER apart from other hydrocodone products currently available:
It does not contain acetaminophen.
It is an extended-release medication.
Other hydrocodone medications currently available (like Vicodin and Lortab) all contain acetaminophen , which can be hard on the liver. They are also all immediate-release, meaning they have to be taken every four to six hours. Zohydro is intended to be administered every 12 hours to provide round-the-clock pain management for an extended period of time.
Under the Prescription Drug User Fee Act, the goal for a standard review of an NDA is 10 months from NDA subm...
New research, funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (one of the National Institutes of Health) shows that the anticonvulsant medication gabapentin (brand name Neurontin ), which is used for certain types of seizures, can be an effective treatment for the pain and other symptoms associated with fibromyalgia . In this randomized, double-blind clinical trial of 150 people (90 percent women) with fibromyalgia, Lesley M. Arnold, M.D., director of the Women's Health Research Program at the University of Cincinnati College of Medicine, and her colleagues found that those taking 1,200 to 2,400 mg of gabapentin daily for 12 weeks displayed significantly less pain than those taking a placebo. Patients taking gabapentin also reported significantly better sleep and less fatigue. For the majority of participants, the drug was well tolerated. The most common side effects included dizziness and sedation, which were mild to moderate in seve...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.